ATRA vs LIN · rev $128.9M vs P/E 34, rev $33.99B
Atara Biotherapeutics Inc (ATRA) versus Linde plc Ordinary Shares (LIN) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Linde plc Ordinary Shares (LIN) is a specialty chemicals company listed on US.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported LIN revenue for 2025-12-31 was $33.99B. Net income was $6.90B. Revenue was up 3.0% from 2024-12-31 to 2025-12-31. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
ATRA currently screens at market cap $87.1M. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
Not investment advice. Open the ATRA and LIN stock pages for the full models.
Not investment advice.